Nexien BioPharma's market cap is currently ―. The company's EPS TTM is $-0.003; its P/E ratio is -4.47; Nexien BioPharma is scheduled to report earnings on November 14, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -73.03K	$ -74.31K	$ -71.15K	$ -164.40K	$ -213.50K
EBITDA	$ -73.03K	$ -74.31K	$ -71.15K	$ -164.40K	$ -213.50K
Net Income Common Stockholders	$ -93.59K	$ -94.87K	$ -97.00K	$ -187.45K	$ -220.19K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 68.99K	$ 101.15K	$ 116.90K	$ 140.22K	$ 2.94K
Total Assets	$ 76.97K	$ 104.96K	$ 124.52K	$ 144.03K	$ 2.94K
Total Debt	$ 213.00K	$ 194.87K	$ 176.73K	$ 149.18K	$ 23.80K
Net Debt	$ 144.01K	$ 93.72K	$ 59.83K	$ 8.97K	$ 20.86K
Total Liabilities	$ 279.29K	$ 265.56K	$ 242.12K	$ 207.29K	$ 65.37K
Stockholders Equity	$ -202.32K	$ -160.60K	$ -117.61K	$ -63.26K	$ -62.42K
Cash Flow	-
Free Cash Flow	$ -32.16K	$ -15.75K	$ -23.32K	$ -21.73K	$ -15.75K
Operating Cash Flow	$ -32.16K	$ -15.75K	$ -23.32K	$ -21.73K	$ -15.75K
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	-
Financing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 159.00K	-

Currency in USD

Nexien BioPharma Earnings and Revenue History

Income Statement >

Nexien BioPharma Debt to Assets

Balance Sheet >

Nexien BioPharma Cash Flow

Cash Flow >

Nexien BioPharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing